On June 21, Novadaq's Roger Deck presented at JMP in a fireside chat format. He highlighted two technical advantages that Novadaq enjoys over the competition.
First, he expounded some of the advantages of Demacell over market leader Alloderm. A soon-to-be published Georgetown study on breast reconstruction will show a decreased time requirement for drainage tube placement. Also, Dermacell needs less handling during implant. The surgeon opens the package and directly places the implant. Whereas, Alloderm requires rinsing before implantation and there is a concern that if not done adequately the implant may not perform properly.
With regards to Pinpoint, the functionality of new 5mm endoscope (previously said to be necessary for 40% of procedures) may not be easily replicated by others (Stryker). At 5mm, due to the smaller cross-sectionand the resulting lower light levels (both on transmission and reception) and Pinpoints's better imaging capability, the superiority of Pinpoint's images against the competition will be "dramatic". (A head-to-head comparison of devices seems to favor Pinpoint, yet again.)